Target intelligence / Profile preview

Ribonucleoprotein PTB-binding 2 (RAVER2)

Target
RAVER2
Molecular classification
Heterogeneous nuclear ribonucleoprotein (hnRNP) family, RNA binding protein, Other
01

Overview

Ribonucleoprotein PTB-binding 2 (RAVER2) is a protein-coding gene and a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family, structurally similar to raver1 and containing three RNA recognition motifs[4][2]. RAVER2 is primarily involved in binding single-stranded nucleic acids and has roles in the regulation of alternative mRNA splicing via the spliceosome[6][7]. It interacts with polypyrimidine tract binding protein (PTB), suggesting a function in PTB-mediated nuclear processes[2]. RAVER2 is localized both in the nucleus and cytoplasm and shows tissue-specific expression, especially in brain, lung, and kidney in adult organisms[2][3][9]. Diseases associated with mutations or altered expression of this gene include leukodystrophy and brachydactyly[6]. There are no current reports of RAVER2 as a direct therapeutic target, or drugs known to specifically target it[6][9].

Other names
RAVER2KIAA1579FLJ10770Protein raver-2ribonucleoprotein PTB-binding 2protein raver-2
02

Biological functions

RNA bindingRegulation of alternative mRNA splicing (via spliceosome)Nucleotide bindingNucleo-cytoplasmic shuttling
03

Disease associations

Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typicalBrachydactyly, type A1Other

Beyond the preview

Go deeper on Ribonucleoprotein PTB-binding 2 (RAVER2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleoprotein PTB-binding 2 (RAVER2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call